Initial Prostate Specific Antigen 1.5 ng/ml or Greater in Men 50 Years Old or Younger Predicts Higher Prostate Cancer Risk EDITORIAL COMMENT

被引：0
|
作者：
Roobol, M. J. [1 ]
机构：
[1] Erasmus MC, Dept Urol, Rotterdam, Netherlands
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 03期
关键词：
D O I：
10.1016/j.juro.2009.11.086
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：950 / 950
页数：1
相关论文
共 50 条
  • [1] Initial Prostate Specific Antigen 1.5 ng/ml or Greater in Men 50 Years Old or Younger Predicts Higher Prostate Cancer Risk
    Tang, Ping
    Sun, Leon
    Uhlman, Matthew A.
    Robertson, Cary N.
    Polascik, Thomas J.
    Albala, David M.
    Donatucci, Craig F.
    Moul, Judd W.
    JOURNAL OF UROLOGY, 2010, 183 (03): : 946 - 950
  • [2] INITIAL PSA >=1.5 NG/ML IN MEN = < 50 YEARS OLD PREDICTS A SUBSEQUENT HIGHER RISK OF PROSTATE CANCER
    Uhlman, Matthew
    Tang, Ping
    Sun, Leon
    Robertson, Cary
    Polascik, Thomas
    Albala, David
    Donatucci, Craig
    Moul, Judd
    JOURNAL OF UROLOGY, 2010, 183 (04): : E666 - E666
  • [3] Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. prostate specific antigen
    Lodding, P
    Aus, G
    Bergdahl, S
    Frösing, R
    Lilja, H
    Pihl, CG
    Hugosson, J
    JOURNAL OF UROLOGY, 1998, 159 (03): : 899 - 903
  • [4] Risk Profiles and Treatment Patterns Among Men Diagnosed as Having Prostate Cancer and a Prostate-Specific Antigen Level Below 4.0 ng/ml Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2011, 185 (01): : 139 - 139
  • [5] Prostate Specific Antigen Velocity Risk Count Predicts Biopsy Reclassification for Men with Very Low Risk Prostate Cancer EDITORIAL COMMENT
    Ploussard, Guillaume
    JOURNAL OF UROLOGY, 2014, 191 (03): : 637 - 637
  • [6] The risk of rapid prostate specific antigen increase in men with baseline prostate specific antigen 2.0 ng/ml or less
    Ito, K
    Yamamoto, T
    Suzuki, K
    Kurokawa, K
    Yamanaka, H
    JOURNAL OF UROLOGY, 2004, 171 (02): : 656 - 660
  • [7] Clinical efficacy of transrectal ultrasound-guided prostate biopsy in men younger than 50 years old with an elevated prostate-specific antigen concentration (&gt;4.0 ng/mL)
    Lu, Chin-Heng
    Lin, Tzu-Ping
    Shen, She Huei
    Huang, Yi-Hsiu
    Chung, Hsiao-Jen
    Kuo, Junne-Yih
    Huang, William J. S.
    Wu, Howard H. H.
    Chang, Yen-Hwa
    Lin, Alex T. L.
    Chen, Kuang-Kuo
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2017, 80 (07) : 413 - 418
  • [8] Pathological Outcome following Radical Prostatectomy in Men with Prostate Specific Antigen Greater than 10 ng/ml and Histologically Favorable Risk Prostate Cancer
    Yu, Jiwoong
    Kwon, Young Suk
    Kim, Sinae
    Han, Christopher Sejong
    Farber, Nicholas
    Kim, Jongmyung
    Byun, Seok Soo
    Kim, Wun-Jae
    Jeon, Seong Soo
    Kim, Isaac Yi
    JOURNAL OF UROLOGY, 2016, 195 (05): : 1464 - 1469
  • [9] A "PSA Pyramid'' for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening
    Randazzo, Marco
    Beatrice, Josef
    Huber, Andreas
    Grobholz, Rainer
    Manka, Lukas
    Chun, Felix K.
    Recker, Franz
    Kwiatkowski, Maciej
    EUROPEAN UROLOGY, 2015, 68 (04) : 591 - 597
  • [10] Value of Real-Time Elastography Targeted Biopsy for Prostate Cancer Detection in Men With Prostate Specific Antigen 1.25 ng/ml or Greater and 4.00 ng/ml or Less
    Aigner, Friedrich
    Pallwein, Leo
    Junker, Daniel
    Schaefer, Georg
    Mikuz, Gregor
    Pedross, Florian
    Mitterberger, Michael Josef
    Jaschke, Werner
    Halpern, Ethan J.
    Frauscher, Ferdinand
    JOURNAL OF UROLOGY, 2010, 184 (03): : 913 - 917
12345